The role of SBRT in oligometastatic patients with liver metastases from breast cancer

Marta Scorsetti, Davide Franceschini, Fiorenza De Rose, Tiziana Comito, Ciro Franzese, Giovanna Masci, Rosalba Torrisi, Luca Viganò, Guido Torzilli

Research output: Contribution to journalArticle

Abstract

Liver metastases from breast cancer are a common occurrence. Local ablative therapies are a promising therapeutic option for these patients, with the potential for a long term disease control in the setting of "oligometastatic patients". Identification of the perfect candidate for local approaches is still challenging and unclear. Stereotactic body radiation therapy (SBRT) is one of the most valuable local therapy, because of great efficiency, low morbidity and minimal invasiveness. In this paper, we reviewed the state of the art in the care of breast cancer patients with liver metastases, with a focus on SBRT.

Original languageEnglish
JournalReports of Practical Oncology and Radiotherapy
DOIs
Publication statusAccepted/In press - Feb 22 2016

Keywords

  • Breast
  • Liver
  • Metastases
  • Radiotherapy
  • SBRT

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging

Fingerprint Dive into the research topics of 'The role of SBRT in oligometastatic patients with liver metastases from breast cancer'. Together they form a unique fingerprint.

  • Cite this

    Scorsetti, M., Franceschini, D., De Rose, F., Comito, T., Franzese, C., Masci, G., Torrisi, R., Viganò, L., & Torzilli, G. (Accepted/In press). The role of SBRT in oligometastatic patients with liver metastases from breast cancer. Reports of Practical Oncology and Radiotherapy. https://doi.org/10.1016/j.rpor.2016.07.008